bioAffinity Technologies, Inc.
Nasdaq · Healthcare · Services-Commercial Physical & Biological Research · San Antonio, TX
BIAF chart
What traders are saying about $BIAF
Latest postsbioAffinity Technologies, Inc. news
- Weekly Recap: Going-concern doubt and CyPath Lung revenue growth
TradingView ·
- How Is CyPath Lung Commercialization Progressing at bioAffinity Technologies (NASDAQ:BIAF)?
Kalkine ·
- bioAffinity Technologies Posts $5.89 Q3 GAAP Loss Per Share
www.tokenpost.com ·
- bioAffinity Technologies grows lung-test sales but flags funding needs
Mugglehead Investment Magazine ·
- bioAffinity Technologies, Inc. (BIAF) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- bioAffinity Technologies, Inc. (BIAF) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Form 8K bioAffinity Technologies Inc For: 6 November By Investing.com
Investing.com Australia ·
- bioAffinity Technologies earnings beat by $25.61, revenue fell short of estimates
Investing.com Nigeria ·
- bioAffinity Technologies, Inc. (BIAF) stock price, news, quote and history
Yahoo Finance UK ·
- bioAffinity Technologies Reports Third Quarter 2026 Results and Continued Momentum in CyPath® Lung Commercialization
Yahoo Finance ·
- bioAffinity Technologies Q3 revenue falls on lower reimbursement
TradingView ·
- bioAffinity Technologies Reports Q3 2026 Results and 79% Year-to-Date Testing Revenue Growth
TradingView ·
bioAffinity Technologies, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $6.2M | $9.4M | $2.5M | $4,803 |
| Net income | -$14.9M | -$9.0M | -$7.9M | -$8.2M |
| Diluted EPS | $-8.66 | $-22.50 | $-0.91 | $-1.81 |
| Total assets (year end) | $11.0M | $6.5M | $8.2M | $12.2M |
| Cash and equivalents (year end) | $6.4M | $1.1M | $2.8M | $11.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About bioAffinity Technologies, Inc.
- Ticker
- BIAF (Nasdaq)
- Industry
- Services-Commercial Physical & Biological Research
- Headquarters
- San Antonio, TX
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1712762
- Former names
- bioAffinity Technologies, Inc.
Frequently asked questions
What exchange is bioAffinity Technologies, Inc. listed on?
bioAffinity Technologies, Inc. trades on the Nasdaq under the ticker symbol BIAF.
What industry is bioAffinity Technologies, Inc. in?
bioAffinity Technologies, Inc. is classified by the SEC under "Services-Commercial Physical & Biological Research", part of the Healthcare sector on StockTweeting.
Where is bioAffinity Technologies, Inc. headquartered?
bioAffinity Technologies, Inc.'s business address on file with the SEC is in San Antonio, TX.
When does bioAffinity Technologies, Inc.'s fiscal year end?
bioAffinity Technologies, Inc.'s fiscal year ends on December 31.
How much revenue did bioAffinity Technologies, Inc. report?
bioAffinity Technologies, Inc. reported $6.2M in revenue for calendar year 2025, according to its SEC filings.